Elective abortion affects patients beyond clinics—shaped by policy, distance, scheduling, and whether care is medical or procedural. Across research, costs and burdens can include travel money and time, as well as barriers like appointment delays. Studies also track outcomes such as continuing pregnancy and complication rates by method, alongside how telehealth and remote support may change access. This page brings those access, affordability, and safety themes together.
Key Takeaways
- In a systematic review, the mean cost to patients for abortion services (medical vs procedural) ranged roughly from $0 to several hundred dollars depending on insurance and setting (patient out-of-pocket costs range).
- In one U.S. analysis, mean travel-related costs were $244 for patients in states requiring longer travel distances (mean travel cost).
- In the U.S., mean total cost (including travel and time) for patients without coverage averaged $700 in 2016 dollars (economic total cost).
- Travel time for abortion care increased by a median of 11 hours for patients in states with restrictive policies compared with states without similar restrictions (median change in travel time).
- In the U.S., 26% of abortion patients reported that their appointment was delayed compared with what they wanted, reflecting scheduling barriers (share reporting delays).
- In 2017, the median travel distance for abortions was 30 miles, while for facilities beyond the nearest provider it increased substantially (median travel distance reported in study).
- The global market for abortion services-related telehealth platforms was estimated at $1.2B in 2023, reflecting growth in digital access channels (market size estimate).
- In the U.S., 14% of abortions in 2020 were provided through telehealth-enabled medication abortion pathways (telehealth pathway share).
- Across OECD countries, medical abortion use increased from 40% in 2010 to 55% in 2020 (trend in share by method).
- In a large systematic review, continuing pregnancy after mifepristone-misoprostol occurred in about 1% of medication abortion cases (continuing pregnancy rate).
- ACOG states that first-trimester aspiration abortion has a risk of major complications well under 1% (risk threshold).
- For procedural abortion, major complication rates are about 0.09% (9 per 10,000) in large U.S. cohorts for first-trimester aspiration (major complication incidence).
- In the U.S., medication abortion can be completed at home for most patients; one study reported that 90% of participants found the process acceptable (patient acceptability rate).
- In England and Wales, 95% of patients reported being satisfied with abortion services in patient surveys (survey satisfaction).
- In a study of telemedicine abortion, 96% of patients reported that they felt supported during care (patient support measure).
Access barriers like travel time and delays can raise costs, even as most patients report satisfaction.
Related reading
01 · Category
Cost Analysis6 stats
01
In a systematic review, the mean cost to patients for abortion services (medical vs procedural) ranged roughly from $0to several hundred dollars depending on insurance and setting (patient out-of-pocket costs range).
02
In one U.S. analysis, mean travel-related costs were $244for patients in states requiring longer travel distances (mean travel cost).
03
In the U.S., mean total cost (including travel and time) for patients without coverage averaged $700in 2016 dollars (economic total cost).
04
In a cost-effectiveness assessment, self-managed medication abortion with remote support achieved higher value per quality-adjusted life year (QALY) than in-person care under access-limited conditions (incremental cost-effectiveness ratio).
05
In a U.S. health system evaluation, enabling telemedicine for medication abortion reduced clinic staffing demand by an estimated 20% (staffing demand change).
06
In a 2018 study, lost time valued as wages contributed the largest non-medical component of abortion cost for many patients (share of non-medical cost component).
Interpretation
Cost Analysis Interpretation
Across cost analysis studies, non-medical expenses like travel and lost wages loom large, with mean travel-related costs of about $244 and patients without coverage averaging roughly $700 in total cost in 2016 dollars, underscoring that affordability is often driven as much by access barriers as by the procedure itself.
02 · Category
Access & Geography4 stats
01
Travel time for abortion care increased by a median of 11 hours for patients in states with restrictive policies compared with states without similar restrictions (median change in travel time).
02
In the U.S., 26% of abortion patients reported that their appointment was delayed compared with what they wanted, reflecting scheduling barriers (share reporting delays).
03
In 2017, the median travel distance for abortions was 30 miles, while for facilities beyond the nearest provider it increased substantially (median travel distance reported in study).
04
In Brazil’s public sector, the median waiting time for elective abortion care increased to 20 days in some settings following policy tightening (waiting time reported in study).
Interpretation
Access & Geography Interpretation
Across access and geography, restrictive policies and distance requirements appear to add substantial real world delays, with travel time rising by a median of 11 hours in the United States and median waiting times reaching 20 days in Brazil’s public sector.
03 · Category
Market Size2 stats
01
The global market for abortion services-related telehealth platforms was estimated at $1.2B in 2023, reflecting growth in digital access channels (market size estimate).
02
In the U.S., 14% of abortions in 2020 were provided through telehealth-enabled medication abortion pathways (telehealth pathway share).
Interpretation
Market Size Interpretation
From a market size perspective, the abortion services telehealth platform sector was valued at about $1.2B in 2023 globally, and in the U.S. telehealth-enabled medication abortion pathways accounted for 14% of abortions in 2020, signaling meaningful and growing consumer demand for digital access.
More related reading
04 · Category
Method & Uptake1 stats
01
Across OECD countries, medical abortion use increased from 40% in 2010 to 55% in 2020 (trend in share by method).
Interpretation
Method & Uptake Interpretation
From 2010 to 2020 in OECD countries, the share of elective abortions done via medical methods rose from 40% to 55%, showing a clear shift in how people access care under the Method and Uptake category.
05 · Category
Clinical Outcomes14 stats
01
In a large systematic review, continuing pregnancy after mifepristone-misoprostol occurred in about 1% of medication abortion cases (continuing pregnancy rate).
02
ACOG states that first-trimester aspiration abortion has a risk of major complications well under 1% (risk threshold).
03
For procedural abortion, major complication rates are about 0.09% (9 per 10,000) in large U.S. cohorts for first-trimester aspiration (major complication incidence).
04
A systematic review found that incomplete abortion occurred in about 1% of medication abortion cases (incomplete abortion incidence).
05
WHO notes that infection rates after medical abortion are low and comparable to procedural methods when recommended regimens are used (infection comparability).
06
Pain is common but is typically manageable: a systematic review reported that moderate-to-severe pain affected a minority of participants during medication abortion (share experiencing moderate-to-severe pain).
07
WHO estimates that 25% of pregnancies that end in unintended pregnancy result in abortion worldwide (share of unintended pregnancies ending in abortion).
08
A Lancet review estimated that unsafe abortion accounts for 8% of maternal deaths worldwide (maternal mortality share).
09
In the U.S. (2002–2014), the rate of abortion-related emergency department visits was low: 2.0 per 100,000 women per month (ED visit rate measure).
10
WHO reports that HIV acquisition risk from unsafe abortion is increased compared with safer services (directional risk statement with quantified estimates in guideline).
11
Medication abortion is associated with fewer procedural complications than surgical methods in a meta-analysis, with a lower risk of uterine injury (comparative injury risk).
12
In a study of follow-up safety, bloodstream infection after first-trimester medication abortion occurred at rates below 0.1% (infection incidence).
13
In an RCT, complete abortion occurred in 95% of participants receiving mifepristone and misoprostol (complete abortion rate).
14
In a meta-analysis, the risk of hemorrhage requiring transfusion for medication abortion is about 0.1% or less (transfusion requirement incidence).
Interpretation
Clinical Outcomes Interpretation
Across clinical outcomes for elective abortion, major complications are consistently rare, with major complication rates around 0.09% for first-trimester aspiration and only about 1% rates of continuing or incomplete pregnancy after medication abortion.
06 · Category
Patient Experience5 stats
01
In the U.S., medication abortion can be completed at home for most patients; one study reported that 90% of participants found the process acceptable (patient acceptability rate).
02
In England and Wales, 95% of patients reported being satisfied with abortion services in patient surveys (survey satisfaction).
03
In a study of telemedicine abortion, 96% of patients reported that they felt supported during care (patient support measure).
04
The proportion of patients reporting manageable pain at home after medication abortion was 88% in a survey study (pain manageability).
05
In a randomized study comparing home vs clinic follow-up, 94% of patients were satisfied with home follow-up (satisfaction rate for follow-up modality).
Interpretation
Patient Experience Interpretation
Across patient experience measures, satisfaction and support are consistently high, with 95% satisfied in England and Wales and 96% feeling supported in telemedicine care, while at home completion and follow up also land strongly, such as 90% finding the medication abortion process manageable.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Christopher Morgan. (2026, February 13). Elective Abortion Statistics. Gitnux. https://gitnux.org/elective-abortion-statistics
MLA
Christopher Morgan. "Elective Abortion Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/elective-abortion-statistics.
Chicago
Christopher Morgan. 2026. "Elective Abortion Statistics." Gitnux. https://gitnux.org/elective-abortion-statistics.
Sources & references
32 datasets cited across this report · attribution is report-level
+16 additional datasets cited (not shown individually)